Cliff Asness's REPL Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 2.57 M shares of Replimune Group, Inc. (REPL) worth $28.41 M, representing 0.01% of the portfolio. First purchased in 2020-Q1, this medium-term investment has been held for 19 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in REPL, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2026, adding 2.31 M shares. Largest reduction occurred in Q1 2024, reducing 17,825 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Replimune Group (REPL) Holding Value Over Time
Track share changes against reported price movement
Quarterly Replimune Group (REPL) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +2.31 M | Add 904.42% | 2.57 M | $11.07 |
| Q1 2026 | +255,495 | New Buy | 255,495 | $7.65 |
| Q3 2025 | -12,212 | Sold Out | 0 | $0.00 |
| Q2 2025 | -1,039 | Reduce 7.84% | 12,212 | $9.29 |
| Q1 2025 | -2,058 | Reduce 13.44% | 13,251 | $9.75 |
| Q4 2024 | -12,477 | Reduce 44.90% | 15,309 | $12.11 |
| Q3 2024 | +27,786 | New Buy | 27,786 | $10.96 |
| Q1 2024 | -17,825 | Sold Out | 0 | $0.00 |
| Q4 2023 | +17,825 | New Buy | 17,825 | $8.43 |
| Q3 2023 | -11,290 | Sold Out | 0 | $0.00 |
| Q2 2023 | +126 | Add 1.13% | 11,290 | $23.22 |
| Q1 2023 | +11,164 | New Buy | 11,164 | $17.66 |
| Q3 2021 | -15,279 | Sold Out | 0 | $0.00 |
| Q2 2021 | -4,563 | Reduce 23.00% | 15,279 | $38.42 |
| Q1 2021 | -8,562 | Reduce 30.14% | 19,842 | $30.49 |
| Q4 2020 | -10,923 | Reduce 27.77% | 28,404 | $38.16 |
| Q3 2020 | +3,738 | Add 10.50% | 39,327 | $23.01 |
| Q2 2020 | -8,962 | Reduce 20.12% | 35,589 | $24.84 |
| Q1 2020 | +44,551 | New Buy | 44,551 | $9.97 |
Cliff Asness's Replimune Group Investment FAQs
Cliff Asness first purchased Replimune Group, Inc. (REPL) in Q1 2020, acquiring 44,551 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Replimune Group, Inc. (REPL) for 19 quarters since Q1 2020.
Cliff Asness's largest addition to Replimune Group, Inc. (REPL) was in Q2 2026, adding 2,566,241 shares worth $28.41 M.
According to the latest 13F filing for Q2 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 2,566,241 shares of Replimune Group, Inc. (REPL), valued at approximately $28.41 M.
As of the Q2 2026 filing, Replimune Group, Inc. (REPL) represents approximately 0.01% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Replimune Group, Inc. (REPL) was 2,566,241 shares, as reported at the end of Q2 2026.